Association of diabetes with prostate cancer risk in the multiethnic cohort

American Journal of Epidemiology

Volumn 169, Issue 8, 2009, Pages 937-945

  Waters, Kevin M ^a   Henderson, Brian E ^a   Stram, Daniel O ^a   Wan, Peggy ^a   Kolonel, Laurence N ^b   Haiman, Christopher A ^a,c  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^b UNIVERSITY OF HAWAII CANCER CENTER   (United States)

^c Mail Code LG591 MC9601 ^*  (United States)

Author keywords

Cohort studies; Diabetes mellitus, type 2; Ethnology; Prostate specific antigen; Prostatic neoplasms

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ANTIGEN; CANCER; COHORT ANALYSIS; DIABETES; DISEASE; HEALTH RISK; RISK FACTOR;

ADULT; AGED; ARTICLE; BODY MASS; CANCER RISK; CANCER SCREENING; CONTROLLED STUDY; DIABETIC PATIENT; DISEASE ASSOCIATION; EDUCATION; ETHNIC DIFFERENCE; ETHNIC GROUP; HUMAN; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PROSTATE CANCER; RACE DIFFERENCE; AFRICAN AMERICAN; AMERICAN INDIAN; ASIAN AMERICAN; CAUCASIAN; COHORT ANALYSIS; COMORBIDITY; ETHNOLOGY; FOLLOW UP; HEALTH SURVEY; HISPANIC; INCIDENCE; MASS SCREENING; MIDDLE AGED; MULTIVARIATE ANALYSIS; PREVALENCE; PROSPECTIVE STUDY; PROSTATE TUMOR; RISK FACTOR; STATISTICS; UNITED STATES;

AFRICAN AMERICANS; AGED; AMERICAN NATIVE CONTINENTAL ANCESTRY GROUP; ASIAN AMERICANS; BODY MASS INDEX; COHORT STUDIES; COMORBIDITY; DIABETES MELLITUS, TYPE 2; ETHNIC GROUPS; EUROPEAN CONTINENTAL ANCESTRY GROUP; FOLLOW-UP STUDIES; HAWAII; HISPANIC AMERICANS; HUMANS; INCIDENCE; LOS ANGELES; MALE; MASS SCREENING; MIDDLE AGED; MULTIVARIATE ANALYSIS; POPULATION SURVEILLANCE; PREVALENCE; PROSPECTIVE STUDIES; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC NEOPLASMS; RISK FACTORS;

EID: 63649151452     PISSN: 00029262     EISSN: 14766256     Source Type: Journal    
DOI: 10.1093/aje/kwp003     Document Type: Article

References (37)

1. Kasper JS, Giovannucci E. A meta-analysis of diabetes mel-litus and the risk of prostate cancer. Cancer Epidemiol Bio-markers Prev. 2006;15(11):2056-2062.
2. Calton BA, Chang SC, Wright ME, et al. History of diabetes mellitus and subsequent prostate cancer risk in the NIH-AARP Diet and Health Study. Cancer Causes Control. 2007; 18(5): 493-503.
3. Giovannucci E, Rimm EB, Stampfer MJ, et al. Diabetes mellitus and risk of prostate cancer. Cancer Causes Control. 1998;9(1):3-9.
4. Gong Z, Neuhouser ML, Goodman PJ, et al. Obesity, diabetes, and risk of prostate cancer: results from the prostate cancer prevention trial. Cancer Epidemiol Biomarkers Prev. 2006; 15(10): 1977-1983.
5. Velicer CM, Dublin S, White E. Diabetes and the risk of prostate cancer: the role of diabetes treatment and complications. Prostate Cancer Prostatic Dis. 2007;10(1):46-51.
6. Rodriguez C, Patel AV, Mondul AM, et al. Diabetes and risk of prostate cancer in a prospective cohort of US men. Am J Epidemiol. 2005; 161 (2): 147-152.
7. Pierce BL, Plymate S, Ostrander EA, et al. Diabetes mellitus and prostate cancer risk. Prostate. 2008;68(10): 1126-1132.
8. Tavani A, Gallus S, Bosetti C, et al. Diabetes and the risk of prostate cancer. Eur J Cancer Prev. 2002;11(2): 125-128.
9. Giovannucci E, Rimm EB, Stampfer MJ, et al. Height, body weight, and risk of prostate cancer. Cancer Epidemiol Biomarkers Prev. 1997;6(8):557-563.
10. Huxley R, James WP, Barzi F, et al. Ethnic comparisons of the cross-sectional relationships between measures of body size with diabetes and hypertension. Obes Rev. 2008;9(suppl 1): 53-61.
11. Fukui M, Tanaka M, Kadano M, et al. Serum prostate-specific antigen level in men with type 2 diabetes. Diabetes Care. 2008;31(5):930-931.
12. Werny DM, Saraiya M, Gregg EW. Prostate-specific antigen values in diabetic and nondiabetic US men, 2001-2002. Am J Epidemiol. 2006;164(10):978-983.
13. Ross LE, Berkowitz Z, Ekwueme DU. Use of the prostate-specific antigen test among U.S. men: findings from the 2005 National Health Interview Survey. Cancer Epidemiol Biomarkers Prev. 2008;17(3):636-644.
14. Abate N, Chandalia M. The impact of ethnicity on type 2 diabetes. J Diabetes Complications. 2003;17(1):39-58.
15. Borrell LN, Crawford ND, Dailo FJ. Race/ethnicity and self-reported diabetes among adults in the National Health Interview Survey: 2000-2003. Public Health Rep. 2007;122(5):616-625.
16. Mau MK, Glanz K, Severino R, et al. Mediators of lifestyle behavior change in Native Hawaiians: initial findings from the Native Hawaiian Diabetes Intervention Program. Diabetes Care. 2001;24(10): 1770-1775.
17. Aluli N. Prevalence of obesity in a Native Hawaiian population. Am J Clin Nutr. 1991;53(6 suppl):1556S-1560S.
18. Brawley OW, Jani AB, Master V. Prostate cancer and race. Curr Probl Cancer. 2007;31(3):211-225.
19. Jemal A, Siegel R, Ward E, et al. Cancer statistics, 2008. CA Cancer J Clin. 2008;58(2):71-96.
20. Kolonel LN, Altshuler D, Henderson BE. The Multiethnic Cohort Study: exploring genes, lifestyle, and cancer risk. Nat Rev Cancer. 2004;4(7):519-527.
21. Kolonel LN, Henderson BE, Hankin JH, et al. A multiethnic cohort in Hawaii and Los Angeles: baseline characteristics. Am J Epidemiol. 2000;151(4):346-357.
22. National Center for Chronic Disease Prevention and Health Promotion. National diabetes fact sheet. Atlanta, GA: Centers for Disease Control and Prevention; 2005. (http://www.cdc.gov/diabetes/pubs/general.htm#what).
23. Cheng I, Yu MC, Koh WP, et al. Comparison of prostate-specific antigen and hormone levels among men in Singapore and the United States. Cancer Epidemiol Biomarkers Prev. 2005;14(7):1692-1695.
24. Smith RA, Cokkinides V, Eyre HJ, et al. American Cancer Society guidelines for the early detection of cancer, 2003. CA Cancer J Clin. 2003;53(1):27-43.
25. Collin SM, Martin RM, Metcalfe C, et al. Prostate-cancer mortality in the USA and UK in 1975-2004: an ecological study. Lancet Oncol. 2008;9(5):445-452.
26. Midthjell K, Holmen J, Biøndal A, et al. Is questionnaire information valid in the study of a chronic disease such as diabetes? The Nord-Trøndelag Diabetes Study. J Epidemiol Community Health. 1992;46(5):537-542.
27. Okura Y, Urban LH, Mahoney DW, et al. Agreement between self-report questionnaires and medical record data was substantial for diabetes, hypertension, myocardial infarction and stroke but not heart failure. J Clin Epidemiol. 2004;57(10): 1096-1103.
28. Walitt BT, Constantinescu F, Katz JD, et al. Validation of self-report of rheumatoid arthritis and systemic lupus erythematosus: the Women's Health Initiative. J Rheumatol. 2008;35(5):811-818.
29. TM (United States). Cancer Causes Control. 2005;16(7):789-797.
30. Fowke JH, Signorello LB, Chang SS, et al. Effects of obesity and height on prostate-specific antigen (PSA) and percentage of free PSA levels among African-American and Caucasian men. Cancer. 2006;107(10):2361-2367.
31. Coker AL, Sanderson M, Zheng W, et al. Diabetes mellitus and prostate cancer risk among older men: population based case-control study. Br J Cancer. 2004;90(11):2171-2175.
32. Mishina T, Watanabe H, Araki H, et al. Epidemiological study of prostatic cancer by matched-pair analysis. Prostate. 1985; 6(4):423-436.
33. Rosenberg DJ, Neugut AI, Ahsan H, et al. Diabetes mellitus and the risk of prostate cancer. Cancer Invest. 2002;20(2): 157-165.
34. Gudmundsson J, Sulem P, Steinthorsdottir V, et al. Two variants on chromosome 17 confer prostate cancer risk, and the one in TCF2 protects against type 2 diabetes. Nat Genet. 2007;39(8):977-983.
35. Thomas G, Jacobs KB, Yeager M, et al. Multiple loci identified in a genome-wide association study of prostate cancer. Nat Genet. 2008;40(3):310-315.
36. Zeggini E, Scott LJ, Saxena R, et al. Meta-analysis of genome-wide association data and large-scale replication identifies additional susceptibility loci for type 2 diabetes. Nat Genet. 2008;40(5):638-645.
37. Meyer P, Zuern C, Hermanns N, et al. The association between paternal prostate cancer and type 2 diabetes [electronic article]. J Carcinog. 2007;6:14.